Free Trial
LON:IXI

IXICO (IXI) Share Price, News & Analysis

GBX 7
0.00 (0.00%)
(As of 05:27 AM ET)
Today's Range
7
7
50-Day Range
6.45
8.18
52-Week Range
6.35
21
Volume
7,142 shs
Average Volume
81,748 shs
Market Capitalization
£3.38 million
P/E Ratio
N/A
Dividend Yield
1.27%
Price Target
N/A
IXI stock logo

About IXICO Stock (LON:IXI)

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. In addition, the company focuses in therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, and orphan and rare diseases. Further, the company engages in the data collection and analysis of neurological disorders. Additionally, it offers drug development analytics, imaging operation, post marketing surveillance, and consultancy services; and end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

IXI Stock Price History

IXI Stock News Headlines

How did they achieve a perfect track record?
If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...
How did they achieve a perfect track record?
If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...
Is IXICO plc (LON:IXI) Potentially Undervalued?
IXICO plc (PYPB.F)
See More Headlines
Receive IXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IXICO and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/20/2020
Today
7/14/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
89
Year Founded
N/A

Profitability

Net Income
£-1,180,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£6.67 million
Cash Flow
GBX 3.11 per share
Book Value
GBX 24 per share

Miscellaneous

Free Float
N/A
Market Cap
£3.38 million
Optionable
Not Optionable
Beta
0.65
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Giulio Cerroni (Age 63)
    CEO & Director
    Comp: $328k
  • Mr. Grant Nash
    CFO, Company Secretary & Executive Director
  • Prof. Daniel Rueckert
    Co-Founder & Member of Scientific Advisory Board
  • Prof. Derek Lionel Glendon Hill (Age 58)
    Co-Founder and President of Regulatory Science & External Relations
    Comp: $387.01k
  • Prof. David Hawkes CPhys
    FInstP, FIPEM, FREng, Ph.D., Co-Founder & Member of Scientific Advisory Board
  • Prof. Joseph Hajnal
    Co-Founder & Member of Scientific Advisory Board
  • Mr. Mark Austin
    Director of Technology
  • Dr. Robin Wolz
    Chief Scientific Officer
  • Ms. Hannah Esfahanian
    HR Manager
  • Dr. John Hall (Age 45)
    Senior Vice President of Business Development

IXI Stock Analysis - Frequently Asked Questions

How have IXI shares performed this year?

IXICO's stock was trading at GBX 12.50 at the beginning of the year. Since then, IXI shares have decreased by 44.0% and is now trading at GBX 7.
View the best growth stocks for 2024 here
.

How were IXICO's earnings last quarter?

IXICO plc (LON:IXI) announced its earnings results on Wednesday, May, 20th. The company reported $1.01 earnings per share (EPS) for the quarter. IXICO had a negative trailing twelve-month return on equity of 9.85% and a negative net margin of 17.67%.

How do I buy shares of IXICO?

Shares of IXI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of IXICO own?

Based on aggregate information from My MarketBeat watchlists, some other companies that IXICO investors own include Motif Bio (MTFB), ReNeuron Group (RENE), Pendragon (PDG), EnQuest (ENQ) and Chariot (CHAR).

This page (LON:IXI) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners